WO2000074635A3 - Delivery of single stranded dna for expression - Google Patents

Delivery of single stranded dna for expression Download PDF

Info

Publication number
WO2000074635A3
WO2000074635A3 PCT/US2000/040134 US0040134W WO0074635A3 WO 2000074635 A3 WO2000074635 A3 WO 2000074635A3 US 0040134 W US0040134 W US 0040134W WO 0074635 A3 WO0074635 A3 WO 0074635A3
Authority
WO
WIPO (PCT)
Prior art keywords
single stranded
expression
delivery
stranded dna
gene
Prior art date
Application number
PCT/US2000/040134
Other languages
French (fr)
Other versions
WO2000074635A2 (en
Inventor
Jon A Wolff
Original Assignee
Mirus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mirus Corp filed Critical Mirus Corp
Priority to EP00938285A priority Critical patent/EP1246532A2/en
Publication of WO2000074635A2 publication Critical patent/WO2000074635A2/en
Publication of WO2000074635A3 publication Critical patent/WO2000074635A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Abstract

Methods are described for generating and delivering a single stranded nucleic acid capable of expressing a gene. The single stranded nucleic acid is delivered to the host cell, where it transfects a host cell resulting in expression of the encoded gene for gene therapy purposes.
PCT/US2000/040134 1999-06-07 2000-06-07 Delivery of single stranded dna for expression WO2000074635A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP00938285A EP1246532A2 (en) 1999-06-07 2000-06-07 Delivery of single stranded dna for expression

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13785599P 1999-06-07 1999-06-07
US60/137,855 1999-06-07

Publications (2)

Publication Number Publication Date
WO2000074635A2 WO2000074635A2 (en) 2000-12-14
WO2000074635A3 true WO2000074635A3 (en) 2002-08-08

Family

ID=22479341

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/040134 WO2000074635A2 (en) 1999-06-07 2000-06-07 Delivery of single stranded dna for expression

Country Status (2)

Country Link
EP (1) EP1246532A2 (en)
WO (1) WO2000074635A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070173465A9 (en) * 1995-10-11 2007-07-26 Monahan Sean D Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene
KR100397275B1 (en) * 2001-03-08 2003-09-17 주식회사 웰진 Novel high-throughput system for functional genomics using unidirectional antisense cDNA library
IL161733A0 (en) * 2001-11-02 2005-11-20 Insert Therapeutics Inc Methods and compositions for therapeutic use of rna interference
CN112195193A (en) * 2020-09-30 2021-01-08 上海交通大学 Application of single-stranded DNA in gene transfection

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532001A (en) * 1993-07-07 1996-07-02 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US5580859A (en) * 1989-03-21 1996-12-03 Vical Incorporated Delivery of exogenous DNA sequences in a mammal
US5705385A (en) * 1995-06-07 1998-01-06 Inex Pharmaceuticals Corporation Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5843742A (en) * 1994-12-16 1998-12-01 Avigen Incorporated Adeno-associated derived vector systems for gene delivery and integration into target cells
US5874555A (en) * 1987-10-30 1999-02-23 California Institute Of Technology Triple helices and processes for making same
US20010007767A1 (en) * 1995-12-15 2001-07-12 Elazar Rabbani Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874555A (en) * 1987-10-30 1999-02-23 California Institute Of Technology Triple helices and processes for making same
US5580859A (en) * 1989-03-21 1996-12-03 Vical Incorporated Delivery of exogenous DNA sequences in a mammal
US5532001A (en) * 1993-07-07 1996-07-02 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US5843742A (en) * 1994-12-16 1998-12-01 Avigen Incorporated Adeno-associated derived vector systems for gene delivery and integration into target cells
US5705385A (en) * 1995-06-07 1998-01-06 Inex Pharmaceuticals Corporation Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US20010007767A1 (en) * 1995-12-15 2001-07-12 Elazar Rabbani Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LEWIS ET AL.: "Angiogenesis by gene therapy: a new horizon for myocardial revascularization?", CARDIOVASCULAR RES., vol. 35, 1 September 1997 (1997-09-01), pages 490 - 497, XP000916748 *
SEGOVIA ET AL.: "Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism", GENE THERAPY, vol. 5, December 1998 (1998-12-01), pages 1650 - 1655, XP002909757 *

Also Published As

Publication number Publication date
WO2000074635A2 (en) 2000-12-14
EP1246532A2 (en) 2002-10-09

Similar Documents

Publication Publication Date Title
AU4077100A (en) Enhancement of the immune response for vaccine and gene therapy applications
AU5788096A (en) Plasmid for delivery of nucleic acids to cells and methods of use
GB2338484B (en) Medicaments comprising a nucleic acid encoding a cell targeting moiety and a prodrug activating enzyme
WO2003093469A3 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
WO2001030965A3 (en) Methods of in vivo gene transfer using a sleeping beauty transposon system
HK1047129A1 (en) Sequence-specific dna recombination in eukaryotic cells
EP0705344B8 (en) Adenovirus vectors for gene therapy
WO2000042561A3 (en) Oligonucleotide mediated nucleic acid recombination
HUP0004728A1 (en) Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor
AU2001265756A1 (en) Sleeping beauty, a transposon vector with a broad host range for the genetic transfprmation in vertebrates
AU1606897A (en) Thymidine kinase variants, corresponding nucleic acid sequences and their use in gene therapy
AU1265097A (en) Nucleic acid constructs for the cell cycle-regulated expression of genes, cells containing such constructs and their use for preparing drugs
AU682140B2 (en) Multidrug resistance gene
WO1999047678A3 (en) Interferon alpha plasmids and delivery systems, and methods of making and using the same
WO1998054313A3 (en) Dna methyltransferase genomic sequences and antisense oligonucleotides
WO2000074635A3 (en) Delivery of single stranded dna for expression
WO2003060066A8 (en) Nucleic acid delivery and expression
WO2000035421A3 (en) Integrative protein-dna cochleate formulations and methods for transforming cells
WO2001036679A3 (en) METHODS FOR GENERATING SINGLE STRANDED cDNA FRAGMENTS
WO2003031459A3 (en) Modulation of the expression of genes dependent on stat-1
WO2002072768A3 (en) ISOGENIC ss-CATENIN CELL LINES, AND METHODS OF MAKING AND USING SAME
EP1086116A4 (en) Compositions and methods for the pulmonary delivery of nucleic acids
AU2114899A (en) Nucleotide expression systems with reduced immunogenicity for use in gene therapy
WO2001066150A3 (en) Highly efficient gene transfer into human repopulating stem cel ls by rd114 pseudotyped retroviral vector particles
WO1999054445A3 (en) Combination therapy using nucleic acids and conventional drugs

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2000938285

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWP Wipo information: published in national office

Ref document number: 2000938285

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000938285

Country of ref document: EP